Back to search

Article

Allogeneic hematopoietic cell transplantation in patients with CALR-mutated myelofibrosis: a study of the Chronic Malignancies Working Party of EBMT

2023-06-29

Abstract excerpt

<title>Abstract</title> <p>Allogeneic hematopoietic cell transplantation (allo-HCT) is curative for myelofibrosis (MF) but assessing risk-benefit in individual patients is challenging. This complexity is amplified in <italic>CALR-</italic>mutated MF patients, as they live longer with conventional treatments compared to other molecular subtypes. We analyzed outcomes of 346 <italic>CALR</italic>-mutated MF patients...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
e1d0adc7-8287-56dc-9428-11a332ccdc3b
DOI
10.21203/rs.3.rs-3108004/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Allogeneic hematopoietic cell transplantation in patients with CALR-mutated myelofibrosis: a study of the Chronic Malignancies Working Party of EBMTDOI 10.21203/rs.3.rs-3108004/v1
Select a neighboring publication to make it the new centre.